Novel spectacle lens design
DeviceUse of spectacle lenses may reduce the rate of progression of juvenile myopia
NCT Number: NCT07008001
This is a randomized, controlled, open-label, evaluator-blinded, multicenter, clinical trial of 12-months duration to evaluate the continued safety and efficacy of Diffusion Optics Technology (DOT) spectacle lenses in reducing the progression of juvenile myopia in children of Chinese origin.
Interested in participating?
Request Info8 year–16 year
All sexes
Interventional
Not applicable
Aier Eye Hospital, Changsha, China
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Use of spectacle lenses may reduce the rate of progression of juvenile myopia
Time frame: 12 months
Change in axial length from baseline to 36 months
Time frame: 12 months
Change in axial length from baseline to 12 months
Contact information is provided by the study sponsor or research team.
Jennifer S Hill, BS
CONTACT
Vanessa Tasso, MA, MBA
CONTACT
SightGlass Vision, Inc.
Industry
Clinical Assessment of DOT Spectacle Lenses in Chinese Children Extension
Acronym: CATHAY Ext
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07229365
Eye Diseases, Juvenile Myopia
Bloomington, Indiana, United States
View Trial DetailsNCT07229352
Eye Diseases, Juvenile Myopia
Glendale, Arizona, United States
View Trial DetailsNCT06034327
Eye Diseases, Juvenile Myopia
Oakland, California, United States
View Trial DetailsNCT05562622
Eye Diseases, Juvenile Myopia
Changsha, China
View Trial Details